Global Softgel Capsules Market by Type (Gelatin-based/Animal-based, Non-animal-based), by End-use (CMO, Pharmaceutical, Nutraceutical, Cosmeceutical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Softgel Capsules Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Softgel Capsules Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Softgel Capsules Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Softgel Capsules Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Softgel Capsules Market Size & Forecast, 2018-2028
4.5.1 Softgel Capsules Market Size and Y-o-Y Growth
4.5.2 Softgel Capsules Market Absolute $ Opportunity
Chapter 5 Global Softgel Capsules Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Softgel Capsules Market Size Forecast by Type
5.2.1 Gelatin-based/Animal-based
5.2.2 Non-animal-based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Softgel Capsules Market Analysis and Forecast by End-use
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End-use
6.1.2 Basis Point Share (BPS) Analysis by End-use
6.1.3 Absolute $ Opportunity Assessment by End-use
6.2 Softgel Capsules Market Size Forecast by End-use
6.2.1 CMO
6.2.2 Pharmaceutical
6.2.3 Nutraceutical
6.2.4 Cosmeceutical
6.3 Market Attractiveness Analysis by End-use
Chapter 7 Global Softgel Capsules Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Softgel Capsules Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Softgel Capsules Analysis and Forecast
9.1 Introduction
9.2 North America Softgel Capsules Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Softgel Capsules Market Size Forecast by Type
9.6.1 Gelatin-based/Animal-based
9.6.2 Non-animal-based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Softgel Capsules Market Size Forecast by End-use
9.10.1 CMO
9.10.2 Pharmaceutical
9.10.3 Nutraceutical
9.10.4 Cosmeceutical
9.11 Basis Point Share (BPS) Analysis by End-use
9.12 Absolute $ Opportunity Assessment by End-use
9.13 Market Attractiveness Analysis by End-use
Chapter 10 Europe Softgel Capsules Analysis and Forecast
10.1 Introduction
10.2 Europe Softgel Capsules Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Softgel Capsules Market Size Forecast by Type
10.6.1 Gelatin-based/Animal-based
10.6.2 Non-animal-based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Softgel Capsules Market Size Forecast by End-use
10.10.1 CMO
10.10.2 Pharmaceutical
10.10.3 Nutraceutical
10.10.4 Cosmeceutical
10.11 Basis Point Share (BPS) Analysis by End-use
10.12 Absolute $ Opportunity Assessment by End-use
10.13 Market Attractiveness Analysis by End-use
Chapter 11 Asia Pacific Softgel Capsules Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Softgel Capsules Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Softgel Capsules Market Size Forecast by Type
11.6.1 Gelatin-based/Animal-based
11.6.2 Non-animal-based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Softgel Capsules Market Size Forecast by End-use
11.10.1 CMO
11.10.2 Pharmaceutical
11.10.3 Nutraceutical
11.10.4 Cosmeceutical
11.11 Basis Point Share (BPS) Analysis by End-use
11.12 Absolute $ Opportunity Assessment by End-use
11.13 Market Attractiveness Analysis by End-use
Chapter 12 Latin America Softgel Capsules Analysis and Forecast
12.1 Introduction
12.2 Latin America Softgel Capsules Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Softgel Capsules Market Size Forecast by Type
12.6.1 Gelatin-based/Animal-based
12.6.2 Non-animal-based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Softgel Capsules Market Size Forecast by End-use
12.10.1 CMO
12.10.2 Pharmaceutical
12.10.3 Nutraceutical
12.10.4 Cosmeceutical
12.11 Basis Point Share (BPS) Analysis by End-use
12.12 Absolute $ Opportunity Assessment by End-use
12.13 Market Attractiveness Analysis by End-use
Chapter 13 Middle East & Africa (MEA) Softgel Capsules Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Softgel Capsules Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Softgel Capsules Market Size Forecast by Type
13.6.1 Gelatin-based/Animal-based
13.6.2 Non-animal-based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Softgel Capsules Market Size Forecast by End-use
13.10.1 CMO
13.10.2 Pharmaceutical
13.10.3 Nutraceutical
13.10.4 Cosmeceutical
13.11 Basis Point Share (BPS) Analysis by End-use
13.12 Absolute $ Opportunity Assessment by End-use
13.13 Market Attractiveness Analysis by End-use
Chapter 14 Competition Landscape
14.1 Softgel Capsules Market: Competitive Dashboard
14.2 Global Softgel Capsules Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eurocaps
14.3.2 Catalent
14.3.3 Sirio Pharma
14.3.4 Procaps Laboratories
14.3.5 Captek
14.3.6 Fuji Capsules Co Ltd
14.3.7 Aenova
14.3.8 Capsugel
14.3.9 Patheon
14.3.10 Soft gel Technologies Inc